Oak Hill Bio ("Oak Hill"), a clinical-stage neonatology and rare disease therapeutics company developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune
The presentation highlights the potential of OHB-607 to prevent bronchopulmonary dysplasia in extremely preterm neonates Oak Hill Bio ("Oak Hill"), a clinical-stage neonatology and rare disease therapeutics
Employees at AstraZeneca China are under investigation for insurance fraud. Takeda has promoted several women to key positions. Samsung has bought out Biogen’s stake in its biosimilar-focused Samsung Bioepis joint venture for $2.3 billion. And more.